SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-24-190317 from RBC FUNDS TRUST (CIK 0001272950)

RBC FUNDS TRUST (CIK 0001272950)
Date: July 31, 2024 · CIK: 0001272950 · Accession: 0001193125-24-190317

AI Filing Summary & Sentiment

File numbers found in text: 811-21475

Date
July 31, 2024
Author
/s/ Stephen T. Cohen
Form
CORRESP
Company
RBC FUNDS TRUST (CIK 0001272950)

Letter

VIA EDGAR Securities and Exchange Commission Division of Investment Management 100 F Street, N.E. Washington, D.C. Attn: Brian Szilagyi Re: RBC Funds Trust (File No. 811-21475) (the “Trust”)

Dear Mr. Szilagyi:

Thank you for your telephonic comments received on July 1, 2024, with respect to your review pursuant to the Sarbanes-Oxley Act of 2002 of the annual report of the Trust filed on Form N-CSR relating to the fiscal year ended March 31, 2024 (the “Annual Reports”) and certain other filings made by the Trust on behalf of certain series (each, a “Fund”). Below, we provide the staff’s comments and our responses to such comments. Any changes will be reflected in the next such filing, except to the extent otherwise noted.

Comment 1.

For RBC Emerging Markets Value Equity Fund, please include all disclosures required for restricted securities in accordance with Rule 12-12 of Regulation S-X.

Response 1. The Funds will include all disclosures required for restricted securities pursuant to Rule 12-12 of Regulation S-X in future filings.

Comment 2.

Please explain why the Funds have not stated that they follow the accounting guidance in accordance with ASC 946-10-50-1.

Response 2. The Funds will include the requested disclosure in future filings.

Comment 3.

The Funds do not contain a statement accompanying the average annual return tables disclosing that the tables do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of fund

shares. Please confirm that the Funds will comply with Item 27(d)(7)(ii)(B) of Form N-1A.

Response 3. The Funds will include the requested disclosure in future filings.

Comment 4.

The Staff notes that Item 4(e)(2) of Form N-CSR discloses 100% for paragraph (c). However, this paragraph describes situations when preapproval was waived, not when preapproval was obtained. Please confirm if this disclosure is accurate.

Response 4. The correct response to paragraph (c) of Item 4(e)(2) is 0%.

Comment 5.

RBC Emerging Markets Equity Fund, RBC China Equity Fund, and RBC Emerging Markets Value Equity Fund each hold foreign currency or invest in foreign denominated investments that may be subject to capital controls. Supplementally, please describe the accounting policy or translation of foreign currency balances and foreign denominated investments when capital controls are in place, citing applicable Regulation S-X, US GAAP, or other applicable US guidance. In your response, please describe the risks presented by capital controls and include details of the nature of the capital controls, exchange rate mechanisms, current economic conditions, and impacts to the Funds’ future cash flows and results of operations. Going forward, please enhance disclosure in accordance with GAAP (FASB ASC 275-10-5) to provide readers of the financial statements with the information necessary to understand the risks presented by capital controls.

Response 5. The financial statements are prepared in accordance with U.S. GAAP. Under ASC 830-20-25-1 and ASC 830-20-30-1, all foreign currency transactions are measured in the functional currency of the recording entity by use of the exchange rate in effect on the date on which the transaction is recognized. All foreign securities denominated in non-U.S. dollars, including foreign currencies that may be subject to capital controls, are valued in the local foreign currency and then converted into the U.S. dollar equivalent using the foreign exchange rate in effect at the close of the NYSE (usually 4 p.m. ET). The spot rate used is received from a third-party pricing service. In accordance with the Funds’ Valuation Procedures and Rule 2a-5 under the Investment Company Act of 1940, as amended, due diligence and oversight of the third-party pricing services used to value the Funds’ assets and securities is performed by the Funds’ investment adviser (the “Adviser”) and the Funds’ Pricing Committee.

The Funds’ administrator has daily tolerance checks in place to identify large variances in FX rates for all prices and valuations from the previous day and investigate those that exceed set thresholds. This process is included in SOC 1 testing performed by an independent audit firm. The administrator may also reach out to the Adviser as needed for confirmation of large FX rate movements.

In response to the request to describe the risks presented by capital controls, we note that investments in countries that have capital controls in place are subject to risks. For example, the Chinese government has capital controls in place which heavily regulate the domestic exchange of foreign currencies and Renminbi (“RMB”) exchange rates in China. Such controls may direct the timing, amount and intervals for effecting conversions, which may adversely affect the operations and financial results of a Fund’s investments in China. In addition, due to capital controls, there is no assurance that there will always be sufficient amounts of RMB available for a Fund to remain invested in Chinese securities at its desired level. In future filings, the Funds will enhance the disclosure regarding capital controls to provide readers of the financial statements with additional information relating to the risks presented by capital controls.

Comment 6.

Item 4(e)(1) of the N-CSR filing says: “[Please verify, please provide further information if this statement is not correct.].” Please clarify.

Response 6. The referenced sentence was an internal note that was inadvertently included in the filing.

If you would like to discuss any of these responses in further detail or if you have any questions, please feel free to contact me at (202) 261-3304.

Best regards,
/s/ Stephen T. Cohen

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 1900 K Street, NW

 Washington, DC 20006-1110

+1  202  261  3300 Main

 +1  202  261  3333
Fax

 www.dechert.com

 STEPHEN T. COHEN

 stephen.cohen@dechert.com

+1 202 261 3304 Direct

 +1 202 261 3024 Fax

 July 31, 2024

 VIA EDGAR

 Securities and Exchange Commission

 Division of
Investment Management

 100 F Street, N.E.

 Washington, D.C.
20549

 Attn: Brian Szilagyi

Re:
 RBC Funds Trust (File No. 811-21475) (the
“Trust”)

 Dear Mr. Szilagyi:

Thank you for your telephonic comments received on July 1, 2024, with respect to your review pursuant to the
Sarbanes-Oxley Act of 2002 of the annual report of the Trust filed on Form N-CSR relating to the fiscal year ended March 31, 2024 (the “Annual Reports”) and certain other filings made by the
Trust on behalf of certain series (each, a “Fund”). Below, we provide the staff’s comments and our responses to such comments. Any changes will be reflected in the next such filing, except to the extent otherwise noted.

Comment 1.

 For RBC Emerging Markets Value Equity Fund, please include all disclosures required for restricted securities in
accordance with Rule 12-12 of Regulation S-X.

Response 1.   The Funds will include all disclosures required for restricted securities pursuant to Rule 12-12 of Regulation
S-X in future filings.

Comment 2.

 Please explain why the Funds have not stated that they follow the accounting guidance in accordance with ASC 946-10-50-1.

 Response 2.   The Funds will include the requested disclosure in future filings.

Comment 3.

 The Funds do not contain a statement accompanying the average annual return tables disclosing that the tables do not
reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of fund

 1

 shares. Please confirm that the Funds will comply with Item 27(d)(7)(ii)(B) of Form
N-1A.

 Response 3.   The Funds will include the requested disclosure in future filings.

Comment 4.

 The Staff notes that Item 4(e)(2) of Form N-CSR discloses 100% for paragraph
(c). However, this paragraph describes situations when preapproval was waived, not when preapproval was obtained. Please confirm if this disclosure is accurate.

 Response 4.   The correct response to paragraph (c) of Item 4(e)(2) is 0%.

Comment 5.

 RBC Emerging Markets Equity Fund, RBC China Equity Fund, and RBC Emerging Markets Value Equity Fund each hold foreign
currency or invest in foreign denominated investments that may be subject to capital controls. Supplementally, please describe the accounting policy or translation of foreign currency balances and foreign denominated investments when capital
controls are in place, citing applicable Regulation S-X, US GAAP, or other applicable US guidance. In your response, please describe the risks presented by capital controls and include details of the
nature of the capital controls, exchange rate mechanisms, current economic conditions, and impacts to the Funds’ future cash flows and results of operations. Going forward, please enhance disclosure in accordance with GAAP (FASB ASC 275-10-5) to provide readers of the financial statements with the information necessary to understand the risks presented by capital controls.

 Response 5.   The financial statements are prepared in accordance with U.S. GAAP. Under ASC 830-20-25-1 and ASC
830-20-30-1, all foreign currency transactions are measured in the functional currency of the recording entity by use of the
exchange rate in effect on the date on which the transaction is recognized. All foreign securities denominated in non-U.S. dollars, including foreign currencies that may be subject to capital controls, are
valued in the local foreign currency and then converted into the U.S. dollar equivalent using the foreign exchange rate in effect at the close of the NYSE (usually 4 p.m. ET). The spot rate used is received from a third-party pricing service. In
accordance with the Funds’ Valuation Procedures and Rule 2a-5 under the Investment Company Act of 1940, as amended, due diligence and oversight of the third-party pricing services used to value the
Funds’ assets and securities is performed by the Funds’ investment adviser (the “Adviser”) and the Funds’ Pricing Committee.

 2

 The Funds’ administrator has daily tolerance checks in place to identify large variances in FX rates for all prices
and valuations from the previous day and investigate those that exceed set thresholds. This process is included in SOC 1 testing performed by an independent audit firm. The administrator may also reach out to the Adviser as needed for confirmation
of large FX rate movements.

 In response to the request to describe the risks presented by capital controls, we note that investments in countries that
have capital controls in place are subject to risks. For example, the Chinese government has capital controls in place which heavily regulate the domestic exchange of foreign currencies and Renminbi (“RMB”) exchange rates in China. Such
controls may direct the timing, amount and intervals for effecting conversions, which may adversely affect the operations and financial results of a Fund’s investments in China. In addition, due to capital controls, there is no assurance that
there will always be sufficient amounts of RMB available for a Fund to remain invested in Chinese securities at its desired level. In future filings, the Funds will enhance the disclosure regarding capital controls to provide readers of the
financial statements with additional information relating to the risks presented by capital controls.

Comment 6.

 Item 4(e)(1) of the N-CSR filing says: “[Please verify, please provide
further information if this statement is not correct.].” Please clarify.

 Response 6.   The referenced sentence was an internal note that was inadvertently included in the
filing.

 If you would like to discuss any of these responses in further detail or if you have any questions, please
feel free to contact me at (202) 261-3304.

 Best regards,

/s/ Stephen T. Cohen

 Stephen T. Cohen

 3